Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis

Biochemical Journal

Volumn 375, Issue 1, 2003, Pages 1-16

  Rutter, Guy A ^a   Da Silva Xavier, Gabriela ^a   Leclerc, Isabelle ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

5 AMP activated protein kinase (AMPK); 5 aminoimidazole 4 carboxamide ribonucleoside (AICAR); Diabetes mellitus; Glucose homoeostasis; Insulin secretion; Pancreatic islet cell

Indexed keywords

CELLS; GLUCOSE; METABOLISM;

GLUCOSE TRANSPORT;

ENZYMES;

FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR; PROTEIN KINASE; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; MULTIENZYME COMPLEX; PROTEIN SERINE THREONINE KINASE;

ADIPOSE TISSUE; CELL SURVIVAL; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCOLIPOTOXICITY; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HEART; HYPOTHALAMUS; INSULIN RELEASE; LIVER; LIVER FUNCTION; LIVER METABOLISM; MAMMAL; METABOLISM; MONOGENIC DISORDER; MUSCLE FUNCTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TOXICITY; ANIMAL; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; GENETICS; HEART MUSCLE; HOMEOSTASIS; PANCREAS ISLET; PHYSIOLOGY;

MAMMALIA;

ADIPOSE TISSUE; ANIMALS; FATTY ACIDS; GLUCOSE; HOMEOSTASIS; HYPOTHALAMUS; INSULIN; ISLETS OF LANGERHANS; LIVER; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; MYOCARDIUM; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES;

EID: 0141905919     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20030048     Document Type: Review

References (233)

1. Cerasi, E. (1992) The aetiology of Type II diabetes. In Insulin, Molecular Biology to Pathology (Ashcroft, F. M. and Ashcroft, S. J. H., eds), pp. 347-381, Oxford University Press, Oxford, New York and Toronto
2. Gale, E. A. (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353-3361
3. DeFronzo, R. A., Bonadonna, R. C. and Ferrannini, E. (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318-368
4. Zimmet, P., Alberti, K. G. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature (London) 414, 782-787
5. King, H., Aubert, R. E. and Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431
6. Astrup, A. and Finer, N. (2000) Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'? Obes. Rev. 1, 57-59
7. Hardie, D. G., Carling, D. and Carlson, M. (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821-855
8. Stapleton, D., Mitchelhill, K. I., Gao, G., Widmer, J., Michell, B. J., Teh, T., House, C. M., Fernandez, C. S., Cox, T., Witters, L. A. and Kemp, B. E. (1996) Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271, 611-614
9. Kemp, B. E., Mitchelhill, K. I., Stapleton, D., Michell, B. J., Chen, Z. P. and Witters, L. A. (1999) Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem. Sci. 24, 22-25
10. Carling, D., Woods, A., Thornton, C., Cheung, P. C., Smith, F. C., Porticos, M. and Stein, S. C. (1997) Molecular characterization of the AMP-activated protein kinase and its role in cellular metabolism. Biochem. Soc. Trans. 25, 1224-1228
11. Carlson, M. (1999) Glucose repression in yeast. Curr. Opin. Microbiol. 2, 202-207
12. Halford, N. G. and Hardie, D. G. (1998) SNF1-related protein kinases: global regulators of carbon metabolism in plants? Plant Mol. Biol. 37, 735-748
13. Winder, W. W. and Hardie, D. G. (1999) AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. Am. J. Physiol. 277, E1-E10
14. Beg, Z. H., Allmann, D. W. and Gibson, D. M. (1973) Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosol. Biochem. Biophys. Res. Commun. 54, 1362-1369
15. Carlson, C. A. and Kim, K. H. (1973) Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J. Biol. Chem. 248, 378-380
16. Yeh, L. A., Lee, K. H. and Kim, K. H. (1980) Regulation of rat liver acetyl-CoA carboxylase. Regulation of phosphorylation and inactivation of acetyl-CoA carboxylase by the adenylate energy charge. J. Biol. Chem. 255, 2308-2314
17. Carling, D., Zammit, V. A. and Hardie, D. G. (1987) A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 223, 217-222
18. Beri, R. K., Marley, A. E., See, C. G., Sopwith, W. F., Aguan, K., Carling, D., Scott, J. and Carey, F. (1994) Molecular cloning, expression and chromosomal localisation of human AMP-activated protein kinase. FEBS Lett. 356, 117-121
19. Stapleton, D., Gao, G., Michell, B. J., Widmer, J., Mitchelhill, K., Teh, T., House, C. M., Witters, L. A., and Kemp, B. E. (1994) Mammalian 5′-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J. Biol. Chem. 269, 29343-29346
20. Carling, D., Aguan, K., Woods, A., Verhoeven, A. J., Beri, R. K., Brennan, C. H., Sidebottom, C., Davison, M. D. and Scott, J. (1994) Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J. Biol. Chem. 269, 11442-11448
21. Alderson, A., Sabelli, P. A., Dickinson, J. R., Cole, D., Richardson, M., Kreis, M., Shewry, P. R. and Halford, N. G. (1991) Complementation of snf1, a mutation affecting global regulation of carbon metabolism in yeast, by a plant protein kinase cDNA. Proc. Natl. Acad. Sci, U.S.A. 88, 8602-8605
22. Smith, F. C., Davies, S. P., Wilson, W. A., Carling, D. and Hardie, D. G. (1999) The SNF1 kinase complex from Saccharomyces cerevisiae phosphorylates the transcriptional repressor protein Mig1p in vitro at four sites within or near regulatory domain 1. FEBS Lett. 453, 219-223
23. DeVit, M. J., Waddle, J. A. and Johnston, M. (1997) Regulated nuclear translocation of the Mig1 glucose repressor. Mol. Biol. Cell 8, 1603-1618
24. DeVit, M. J. and Johnston, M. (1999) The nuclear exportin msn5 is required for nuclear export of the mig1 glucose repressor of saccharomyces cerevisiae. Curr. Biol. 9, 1231-1241
25. Hirsch, T., Marchetti, P., Susin, S. A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M. and Kroemer, G. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573-1581
26. Halestrap, A. P., McStay, G. P. and Clarke, S. J. (2002) The permeability transition pore complex: another view. Biochimie 84, 153-166
27. Ruderman, N. B., Saha, A. K., Vavvas, D. and Witters, L. A. (1999) Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 276, E1-E18
28. Hawley, S. A., Gadalla, A. E., Olsen, G. S. and Hardie, D. G. (2002) The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420-2425
29. Fryer, L. G., Parbu-Patel, A. and Carling, D. (2002) The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277, 25226-25232
30. da Silva Xavier, G., Leclerc, I., Salt, I. P., Doiron, B., Hardie, D. G., Kahn, A. and Rutter, G. A. (2000) Role of AMP-activated protein kinase in the regulation by glucose of islet beta-cell gene expression. Proc. Natl. Acad. Sci. U.S.A. 97, 4023-4028
31. da Silva Xavier, G., Leclerc, I., Varadi, A., Tsuboi, T., Moule, S. K. and Rutter, G. A. (2003) Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem. J. 371, 761-774
32. Salt, I. P., Johnson, G., Ashcroft, S. J. and Hardie, D. G. (1998) AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem. J. 335, 533-539
33. Eto, K., Yamashita, T., Matsui, J., Terauchi, Y., Noda, M. and Kadowaki, T. (2002) Genetic manipulations of fatty acid metabolism in beta-cells are associated with dysregulated insulin secretion. Diabetes 51 (Suppl. 3), S414-S420
34. Zhang, S. and Kim, K. H. (1995) Glucose activation of acetyl-CoA carboxylase in association with insulin secretion in a pancreatic beta-cell line. J. Endocrinol. 147, 33-41
35. Minokoshi, Y. and Kahn, B. B. (2003) Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem. Soc. Trans. 31, 196-201
36. Stapleton, D., Woollatt, E., Mitchelhill, K. I., Nicholl, J. K., Fernandez, C. S., Michell, B. J., Witters, L. A., Power, D. A., Sutherland, G. R. and Kemp, B. E. (1997) AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett. 409, 452-456
37. Kemp, B. E., Stapleton, D., Campbell, D. J., Chen, Z. P., Murthy, S., Walter, M., Gupta, A., Adams, J. J., Katsis, F., van Denderen, B. et al. (2003) AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans. 31, 162-168
38. Cheung, P. C. F., Salt, I. P., Davies, S. P., Hardie, D. G. and Carling, D. (2000) Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346, 659-669
39. Hardie, D. G. and Carling, D. (1997) The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur. J. Biochem. 246, 259-273
40. Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S. C., Lemarchand, P., Ferre, P., Foufelle, F. and Carling, D. (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. 20, 6704-6711
41. Chen, Z., Heierhorst, J., Mann, R. J., Mitchelhill, K. I., Michell, B. J., Witters, L. A., Lynch, G. S., Kemp, B. E. and Stapleton, D. (1999) Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. FEBS Lett. 460, 343-348
42. Gao, G., Fernandez, C. S., Stapleton, D., Auster, A. S., Widmer, J., Dyck, J. R., Kemp, B. E. and Witters, L. A. (1996) Non-catalytic beta- and gamma-subunit isoforms of the 5′-AMP-activated protein kinase. J. Biol. Chem. 271, 8675-8681
43. Warden, S. M., Richardson, C., O'Donnell, Jr, J., Stapleton, D., Kemp, B. E. and Witters, L. A. (2001) Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 354, 275-283
44. Mitchelhill, K. I., Michell, B. J., House, C. M., Stapleton, D., Dyck, J., Gamble, J., Ullrich, C., Witters, L. A. and Kemp, B. E. (1997) Posttranslational modifications of the 5′-AMP-activated protein kinase beta1 subunit. J. Biol. Chem. 272, 24475-24479
45. Hudson, E. R., Pan, D. A., James, J., Lucocq, J. M., Hawley, S. A., Green, K. A., Baba, O., Terashima, T. and Hardie, D. G. (2003) A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13, 861-866
46. Polekhina, G., Gupta, A., Michell, B. J., van Denderen, B., Murthy, S., Feil, S. C., Jennings, I. G., Campbell, D. J., Witters, L. A., Parker, M. W. et al. (2003) AMPK beta subunit targets metabolic stress sensing to glycogen. Curr. Biol. 13, 867-871
47. Bateman, A. (1997) The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem. Sci. 22, 12-13
48. Daniel, T. and Carling, D. (2002) Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J. Biol. Chem. 277, 51017-51024
49. Blair, E., Redwood, C., Ashrafian, H., Oliveira, M., Broxholme, J., Kerr, B., Salmon, A., Ostman-Smith, I. and Watkins, H. (2001) Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10 1215-1220
50. Milan, D., Jeon, J. T., Looft, C., Amarger, V., Robic, A., Thelander, M., Rogel-Gaillard, C., Paul, S., Iannuccelli, N., Rask, L. et al. (2000) A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288, 1248-1251
51. Prochazka, M., Farook, V. S., Ossowski, V., Wolford, J. K. and Bogardus, C. (2002) Variant screening of PRKAB2, a type 2 diabetes mellitus susceptibility candidate gene on 1q in Pima Indians. Mol. Cell Probes 16, 421-427
52. Hardie, D. G., Salt, I. P., Hawley, S. A. and Davies, S. P. (1999) AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338, 717-722
53. Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D. and Hardie, D. G. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879-27887
54. Wilkie, D. R. (1986) Muscular fatigue: effects of hydrogen ions and inorganic phosphate. Fed. Proc. Fed. Am. Soc. Exp. Biol. 45, 2921-2923
55. Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A. and Shulman, R. G. (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322, 223-228
56. DeFronzo, R. A., Gunnarsson, R., Bjorkman, O., Olsson, M. and Wahren, J. (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 76, 149-155
57. Dohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E. G., Meelheim, D., Fushiki, T., Atkinson, S. M., Elton, C. W. and Caro, J. F. (1988) An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82, 486-494
58. Cushman, S. W. and Wardzala, L. J. (1980) Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J. Biol. Chem. 255, 4758-4762
59. Ryder, J. W., Chibalin, A. V. and Zierath, J. R. (2001) Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle. Acta Physiol. Scand. 171, 249-257
60. Oatey, P. B., VanWeering, D. J., Dobson, S. P., Gould, G. W. and Tavare, J. M. (1997) GLUT4 vesicle dynamics in living 3T3 L1 adipocytes visualized with green-fluorescent protein. Biochem. J. 327, 637-642
61. Goodyear, L. J. and Kahn, B. B. (1998) Exercise, glucose transport, and insulin sensitivity. Annu. Rev. Med. 49, 235-261
62. Mu, J., Brozinick, Jr, J. T., Valladares, O., Bucan, M. and Birnbaum, M. J. (2001) A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7, 1085-1094
63. Moore, M. C. and Cherrington, A. D. (1996) The nerves, the liver, and the route of feeding: an integrated response to nutrient delivery. Nutrition 12, 282-284
64. Burcelin, R., Crivelli, V., Perrin, C., Da Costa, A., Mu, J., Kahn, B. B., Birnbaum, M. J., Kahn, C. R., Vollenweider, P. and Thorens, B. (2003) GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J. Clin. Invest. 111, 1555-1562
65. Koretsky, A. P., Katz, L. A. and Balaban, R. S. (1989) The mechanism of respiratory control in the in vivo heart. J. Mol. Cell. Cardiol. 21, 59-66
66. Hutber, C. A., Hardie, D. G. and Winder, W. W. (1997) Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am. J. Physiol. 272, E262-E266
67. Vavvas, D., Apazidis, A., Saha, A. K., Gamble, J., Patel, A., Kemp, B. E., Witters, L. A. and Ruderman, N. B. (1997) Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 272, 13255-13261
68. Winder, W. W. (1998) Intramuscular mechanisms regulating fatty acid oxidation during exercise. Adv. Exp. Med. Biol. 441, 239-248
69. Park, H., Kaushik, V. K., Constant, S., Prentki, M., Przybytkowski, E., Ruderman, N. B. and Saha, A. K. (2002) Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277, 32571-32577
70. Randle, P. J., Garland, P. J., Hales, C. N. and Newsholme, E. A. (1963) The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i, 7285-7289
71. Frederich, M. and Balschi, J. A. (2002) The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J. Biol. Chem. 277, 1928-1932
72. Hayashi, T., Hirshman, M. F., Kurth, E. J., Winder, W. W. and Goodyear, L. J. (1998) Evidence for 5′AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47, 1369-1373
73. Merrill, G. F., Kurth, E. J., Hardie, D. G. and Winder, W. W. (1997) AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273, E1107-E1112
74. Bergeron, R., Russell, R. R., Young, L. H., Ren, J. M., Marcucci, M., Lee, A. and Shulman, G. I. (1999) Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am. J. Physiol. 276, E938-E944
75. Holloszy, J. O. and Hansen, P. A. (1996) Regulation of glucose transport into skeletal muscle. Rev. Physiol. Biochem. Pharmacol. 128, 99-193
76. Bergeron, R., Russell, R. R., Young, L. H., Ren, J. M., Marcucci, M., Lee, A. and Shulman, G. I. (1999) Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am. J. Physiol. 276, E938-E944
77. Kurth-Kraczek, E. J., Hirshman, M. F., Goodyear, L. J. and Winder, W. W. (1999) 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48, 1667-1671
78. Barnes, K., Ingram, J. C., Porras, O. H., Barros, L. F., Hudson, E. R., Fryer, L. G., Foufelle, F., Carling, D., Hardie, D. G. and Baldwin, S. A. (2002) Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 115, 2433-2442
79. Danchin, A. and Buc, H. (1972) Proton magnetic resonance studies on 5′-AMP site in glycogen phosphorylase b. FEBS Lett. 22, 289-293
80. Thong, F. S. and Graham, T. E. (2002) The putative roles of adenosine in insulin- and exercise-mediated regulation of glucose transport and glycogen metabolism in skeletal muscle. Can. J. Appl. Physiol. 27, 152-178
81. Fryer, L. G., Parbu-Patel, A. and Carling, D. (2002) Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino-4-imidazolecarboxamide riboside. FEBS Lett. 531, 189-192
82. 2+-induced regulation of ion channel and MAP kinase functions. Nature (London) 376, 737-745
83. Chen, H. C., Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., Standaert, M., Fatese, R. V., Jr. and Farese, R. V. (2002) Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport. J. Biol. Chem. 277, 23554-23562
84. Wojtaszewski, J. F., Nielsen, P., Hansen, B. F., Richter, E. A. and Kiens, B. (2000) Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J. Physiol. (Cambridge, U.K.) 528, 221-226
85. Barnes, B. R., Ryder, J. W., Steiler, T. L., Fryer, L. G., Carling, D. and Zierath, J. R. (2002) Isoform-specific regulation of 5′ AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction. Diabetes 51, 2703-2708
86. Beauloye, C., Marsin, A. S., Bertrand, L. Krause, U., Hardie, D. G., Vanoverschelde, J. L. and Hue, L. (2001) Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett. 505, 348-352
87. Marsin, A. S., Bouzin, C., Bertrand, L. and Hue, L. (2002) The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J. Biol. Chem. 277, 30778-30783
88. Opie, L. H., Mansford, K. R. and Owen, P. (1971) Effects of increased heart work on glycolysis and adenine nucleotides in the perfused heart of normal and diabetic rats. Biochem. J. 124, 475-490
89. Beauloye, C., Marsin, A. S., Bertrand, L., Vanoverschelde, J. L., Rider, M. H. and Hue, L. (2002) The stimulation of heart glycolysis by increased workload does not require AMP-activated protein kinase but a wortmannin-sensitive mechanism. FEBS Lett. 531, 324-328
90. Neely, J. R., Denton, R. M., England, P. J. and Randle, P. J. (1972) The effects of increased heart work on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem. J. 128, 147-159
91. From, A. H., Petein, M. A., Michurski, S. P, Zimmer, S. D. and Ugurbil, K. (1986) 31P-NMR studies of respiratory regulation in the intact myocardium. FEBS Lett. 206, 257-261
92. Viollet, B., Andreelli, F., Jorgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M. et al. (2003) The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 111, 91-98
93. Kuhn, R., Schwenk, F., Aguet, M. and Rajewsky, K. (1995) Inducible gene targeting in mice. Science 269, 1427-1429
94. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. and Friedman, J. M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature (London) 372, 425-432
95. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174
96. Minokoshi, Y., Kim, Y. B., Peroni, O. D., Fryer, L. G., Muller, C., Carling, D. and Kahn, B. B. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature (London) 415, 339-343
97. Unger, R. H., Zhou, Y. T. and Orci, L. (1999) Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc. Natl. Acad. Sci. U.S.A. 96, 2327-2332
98. Kahn, B. B. and Flier, J. S. (2000) Obesity and insulin resistance. J. Clin. Invest. 106, 473-481
99. Steinberg, G. R., Rush, J. W. and Dyck, D. J. (2002) AMP-kinase expression and phosphorylation are increased in rodent muscle following chronic leptin treatment. Am. J. Physiol. Endocrinol. Metab. 284, E648-E654
100. Atkinson, L. L., Fischer, M. A. and Lopaschuk, G. D. (2002) Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J. Biol. Chem. 277, 29424-29430
101. Wojtaszewski, J. F., Jorgensen, S. B., Hellsten, Y., Hardie, D. G. and Richter, E. A. (2002) Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51, 284-292
102. Halse, R., Fryer, L. G., McCormack, J. G., Carling, D. and Yeaman, S. J. (2003) Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase. Diabetes 52, 9-15
103. Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S., Schulman, G. I., Magnuson, M. A. and Kahn, C. R. (2000) Loss of insulin signaling in hepatocyes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87-97
104. Pagliassotti, M. J. and Cherrington, A. D. (1992) Regulation of net hepatic glucose uptake in vivo. Annu. Rev. Physiol. 54, 847-860
105. Bailey, C. J. and Turner, R. C. (1996) Metformin. N. Engl. J. Med. 334, 574-579
106. Wollen, N. and Bailey, C. J. (1988) Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin. Biochem. Pharmacol. 37, 4353-4358
107. Owen, M. R., Doran, E. and Halestrap, A. P. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614
108. Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S. et al. (2002) Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-2081
109. Leclerc, I., Kahn, A. and Doiron, B. (1998) The 5′-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett. 431, 180-184
110. Foretz, M., Carling, D., Guichard, C., Ferre, P. and Foufelle, F. (1998) AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J. Biol. Chem. 273, 14767-14771
111. Hubert, A., Husson, A., Chedeville, A. and Lavoinne, A. (2000) AMP-activated protein kinase counteracted the inhibitory effect of glucose on the phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes. FEBS Lett. 481, 209-212
112. Lochhead, P. A., Salt, I. P., Walker, K. S., Hardie, D. G. and Sutherland, C. (2000) 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 49, 896-903
113. Brown, M. S. and Goldstein, J. L. (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340
114. Osborne, T. F. (2000) Sterol regulatory element-binding proteins (SREBPs): Key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275, 32379-32382
115. Leclerc, I., Lenzner, C., Gourdon, L., Vaulont, S., Kahn, A. and Viollet, B. (2001) Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 50, 1515-1521
116. Sladek, F. M., Zhong, W. M., Lai, E. and Darnell, Jr, J. E. (1990) Liver-enriched transcription factor HNF4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4, 2353-2365
117. Stoffel, M. and Duncan, S. A. (1997) The maturity-onset diabetes of the young (MODY1) transcription factor HNF4 alpha regulates expression of genes required for glucose transport and metabolism. Proc. Natl. Acad. Sci. U.S.A. 94, 13209-13214
118. Bartoov-Shifman, R., Hertz, R., Wang, H., Wollheim, C. B., Bar-Tana, J. and Walker, M. D. (2002) Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4 alpha. J. Biol. Chem. 277, 25914-25919
119. Sladek, F. M., Dallas-Yang, Q. and Nepomuceno, L. (1998) MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization. Diabetes 47, 985-990
120. Navas, M. A., Munoz-Elias, E. J., Kim, J., Shih, D. and Stoffel, M. (1999) Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes 48, 1459-1465
121. Lausen, J., Thomas, H., Lemm, I., Bulman, M, Borgschulze, M., Lingott, A., Hattersley, A. T. and Ryffel, G. U. (2000) Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res. 28, 430-437
122. Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M. and Bell, G. I. (1996) Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature (London) 384, 458-460
123. Hattersley, A. T. (1998) Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabetic Med. 15, 15-24
124. Hong, Y. H., Varanasi, U. S., Yang, W. and Leff, T. (2003) AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J. Biol. Chem. 278, 27495-27501
125. Arden, K. C. and Biggs, III, W. H. (2002) Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch. Biochem. Biophys. 403, 292-298
126. Barthel, A., Schmoll, D., Kruger, K. D., Roth, R. A. and Joost, H. G. (2002) Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Regul. Pept. 143, 3183-3186
127. Diraison, F., Ferré, P., Fouielle, F. and Rutter, G. A. (2002) Impact of over-expression of sterol response element binding protein (SREBP1c) on glucose-stimulated insulin secretion from rat islets. Diabetologia 45, A151
128. Yamashita, H., Takenoshita, M., Sakurai, M., Bruick, R. K., Henzel, W. J., Shillinglaw, W., Arnot, D. and Uyeda, K. (2001) A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad. Sci. U.S.A. 98, 9116-9121
129. Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T. and Uyeda, K. (2002) Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem. 277, 3829-3835
130. Tontonoz, P., Hu, E. and Spiegelman, B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147-1156
131. Willson, T. M., Lambert, M. H. and Kliewer, S. A. (2001) Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu. Rev. Biochem. 70, 341-367
132. Barroso, I., Gurnell, M., Crowley, V. E., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D., Lewis, H., Schafer, A. J. et al. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance diabetes mellitus and hypertension. Nature (London) 402, 880-883
133. Leff, T. (2003) AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem. Soc. Trans. 31, 224-227
134. Habinowski, S. A. and Witters, L. A. (2001) The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 286, 852-856
135. Leclerc, I., da Silva Xavier, G. and Rutter, G. A. (2002) AMP- and stress activated protein kinases: key regulators of gene transcription in mammalian cells. Prog. Nucleic Acid Res. Mol. Biol. 71, 69-90
136. Salt, I. P., Connell, J. M. C. and Gould, G. W. (2000) 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49, 1649-1656
137. Moule, S. K. and Denton, R. M. (1998) The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439, 287-290
138. Corton, J. M., Gillespie, J. G., Hawley, S. A. and Hardie, D. G. (1995) 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 229, 558-565
139. Sullivan, J. E., Brocklehurst, K. J., Marley, A. E., Carey, F., Carling, D. and Beri, R. K. (1994) Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353, 33-36
140. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T. and Hidaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265, 5267-5272
141. Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D. E. and Graybiel, A. M. (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275-2279
142. de Rooij, J., Zwartkruis, F. J., Verheijen, M. H., Cool, R. H., Nijman, S. M., Wittinghofer, A. and Bos, J. L. (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature (London) 396, 474-477
143. Zwartkruis, F. J. and Bos, J. L. (1999) Ras and Rap1: two highly related small GTPases with distinct function. Exp. Cell Res. 253, 157-165
144. Horman, S., Browne, G., Krause, U., Patel, J., Vertommen, D., Bertrand, L., Lavoinne, A., Hue, L., Proud, C. and Rider, M. (2002) Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12, 1419-1423
145. Bolster, D. R., Crazier, S. J., Kimball, S. R. and Jefferson, L. S. (2002) AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277, 23977-23980
146. Wang, W., Fan, J., Yang, X., Furer-Galban, S., Lopez, de Silanes, I., von Kobbe, C., Guo, J., Georas, S. N., Foufelle, F., Hardie, D. G. et al. (2002) AMP-activated kinase regulates cytoplasmic HuR. Mol. Cell. Biol. 22, 3425-3436
147. Schwenke, W. D., Soboll, S., Seitz, H. J. and Sies, H. (1981) Mitochondrial and cytosolic ATP/ADP ratios in rat liver in vivo. Biochem. J. 200, 405-408
148. Detimary, P., Jonas, J. C. and Henquin, J. C. (1995) Possible links between glucose-induced changes in the energy state of pancreatic B cells and insulin release unmasking by decreasing a stable pool of adenine nucleotides in mouse islets. J. Clin. Invest. 96, 1738-1745
149. 2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Biochem. J. 333, 269-274
150. Kennedy, H. J., Pouli, A. E., Jouaville, L. S., Rizzuto, R. and Rutter, G. A. (1999) Glucose-induced ATP microdomains in single islet beta-cells. J. Biol. Chem. 274, 13281-13291
151. Aguilar-Bryan, L. and Bryan, J. (1999) Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr. Rev. 20, 101-135
152. Safayhi, H., Haase, H., Kramer, U., Bihlmayer, A., Roenfeldt, M., Ammon, H. P., Froschmayr, M., Cassidy, T. N., Morano, I., Ahlijanian, M. K. and Striessnig, J. (1997) L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINmSF cells. Mol. Endocrinol. 11, 619-629
153. Rutter, G. A. (2001) Nutrient-secretion coupling in the pancreatic islet β-cell: Recent advances. Mol. Aspects Med. 22, 247-284
154. Bell, G. I., Kayano, T., Buse, J. B., Burant, C. F., Takeda, J., Lin, D., Fukumoto, H. and Seino, S. (1990) Molecular biology of mammalian glucose transporters. Diabetes Care 13, 198-208
155. Schuit, F. C. (1997) Is GLUT2 required for glucose sensing? Diabetologia 40, 104-111
156. Matschinsky, F. M., Ghosh, A. K., Meglasson, M. D., Prentki, M., June, V. and Allman, D. (1986) Metabolic concomitants in pure, pancreatic beta cells during glucose-stimulated insulin secretion. J. Biol. Chem. 261, 14057-14061
157. Iynedjian, P. B. (1993) Mammalian glucokinase and its gene. Biochem. J. 293, 1-13
158. Matschinsky, F. M., Meglasson, M., Ghosh, A., Appel, M., Bedoya, F., Prentki, M., Corkey, B., Shimizu, T., Berner, D., Najati, H. et al. (1986) Biochemical design features of the pancreatic islet cell glucose-sensory system. Adv. Exp. Med. Biol. 211, 459-469
159. 2+ and secretion. EMBO J. 9, 53-60
160. Hutton, J. C., Sener, A., Herchuelz, A., Atwater, I., Kawazu, S., Boschero, A. C., Somers, G., Devis, G. and Malaisse, W. J. (1980) Similarities in the stimulus-secretion coupling mechanisms of glucose- and 2-keto acid-induced insulin release. Endocrinology 106, 203-219
161. Welsh, M., Hellerstrom, C. and Andersson, A. (1982) Respiration and insulin release in mouse pancreatic islets. Effects of L-leucine and 2-ketoisocaproate in combination with D-glucose and L-glutamine. Biochim. Biophys. Acta 721, 178-184
162. Aspinwall, C. A., Lakey, J. R. and Kennedy, R. T. (1999) Insulin-stimulated insulin secretion in single pancreatic beta cells. J. Biol. Chem. 274, 6360-6365
163. Panten, U., Christians, J., Kriegstein, E. V., Poser, W. and Hasselblatt, A. (1973) Effect of carbohydrates upon fluorescence of reduced pyridine nucleotides from perifused isolated pancreatic islets. Diabetologia 9, 477-482
164. Ainscow, E. K., Zhao, C. and Rutter, G. A. (2000) Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 49, 1149-1155
165. Patterson, G. H., Knobel, S. M., Arkhammar, P., Thastrup, O. and Piston, D. W. (2000) Separation of the glucose-stimulated cytoplasmic mitochondrial NAD(P)H responses in pancreatic islet beta cells. Proc. Natl. Acad. Sci. U.S.A. 97, 5203-5207
166. Leclerc, I., Woldersdorf, W., Diraison, F. and Rutter, G. A. (2003) Glucose regulation of 5′ AMP activated protein kinase in intact islets. Diabetic Med. 20, S2, A72
167. Malaisse, W. J., Conget, I., Sener, A. and Rorsman, P. (1994) Insulinotropic action of AICA riboside. II. Secretory, metabolic and cationic aspects. Diabetes Res. 25, 25-37
168. Akkan, A. G. and Malaisse, W. J. (1994) Insulinotropic action of AICA riboside. I. Insulin release by isolated islets and the perfused pancreas. Diabetes Res. 25, 13-23
169. Habinowski, S. A., Hirshman, M., Sakamoto, K., Kemp, B. E., Gould, S. J., Goodyear, L. J. and Witters, L. A. (2001) Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. Arch. Biochem. Biophys. 396, 71-79
170. Hohmeier, H. E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M. and Newgard, C. B. (2000) Isolation of INS-1-derived cell lines with robust ATP-sensifive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49, 424-430
171. Corkey, B. E., Deeney, J. T., Yaney, G. C., Tornheim, K. and Prentki, M. (2000) The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. J. Nutr. 130, 299S-304S
172. Deeney, J. T., Gromada, J., Hoy, M., Olsen, H. L., Rhodes, C. J., Prentki, M., Berggren, P. O. and Corkey, B. E. (2000) Acute stimulation with long chain acyl-CoA enhances exocytosis in insulin secreting cells (HIT T-15 and NMRI beta-cells). J. Biol. Chem. 275, 9363-9368
173. Henquin, J. C. (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49, 1751-1760
174. Woods, A., Salt, I., Scott, J., Hardie, D. G. and Carling, D. (1996) The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397, 347-351
175. Varadi, A., Ainscow, E. K., Allan, V. J. and Rutter, G. A. (2002) Involvement of conventional kinesin in glucose-stimulated secretory-granule movements and exocytosis in clonal pancreatic β-cells. J. Cell Sci. 115, 4177-4189
176. Li, G., Rungger-Brandle, E., Just, I., Jonas, J. C., Aktories, K. and Wollheim, C. B. (1994) Effect of disruption of actin filaments by Clostridium botulinum C2 toxin on insulin secretion in HIT-T15 cells and pancreatic islets. Mol. Biol. Cell 5, 1199-1213
177. 2+-dependent actin-binding protein in a hamster insulin-secreting cell line. J. Clin. Invest. 75, 1015-1022
178. Inagaki, N., Gonoi, T., Clement, IV, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S. and Bryan, J. (1995) Reconstitution of I(KATP): An inward rectifier subunit plus the sulfonylurea receptor. Science 270, 1166-1170
179. Nishida, M. and MacKinnon, R. (2002) Structural basis of inward rectification: cytoplasmic pore of the G protein-gated inward rectifier GIRK1 at 1.8 A resolution. Cell 111, 957-965
180. Piao, H., Cui, N., Xu, H., Mao, J., Rojas, A., Wang, R., Abdulkadir, L., Li, L., Wu, J. and Jiang, C. (2001) Requirement of multiple protein domains and residues for gating K(ATP) channels by intracellular pH. J. Biol. Chem. 276, 36673-36680
181. Bryan, J. and Aguilar-Bryan, L. (1997) The ABCs of ATP-sensitive potassium channels: more pieces of the puzzle. Curr. Opin. Cell Biol. 9, 553-559
182. Gribble, F. M. and Reimann, F. (2002) Pharmacological modulation of KATP channels. Biochem. Soc. Trans. 30, 333-339
183. Ligon, B., Boyd, A. E. and Dunlap, K. (1998) Class A calcium channel variants in pancreatic islets and their role in insulin secretion. J. Biol. Chem. 273, 13905-13911
184. 2+ channel: perspectives for new pharmacological targets. J. Pharmacol. Exp. Ther. 300, 724-728
185. 2+-dependent inactivation of L-type calcium channels. Neuron 22, 549-558
186. Klumpp, S. and Krieglstein, J. (2002) Phosphorylation and dephosphorylation of histidine residues in proteins. Eur. J. Biochem. 269, 1067-1071
187. Meisse, D., Van de Casteele, M., Beauloye, C., Hainault, I., Kefas, B., Rider, M., Foufelle, F. and Hue, L. (2002) Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett. 526, 38-42
188. Kefas, B. A., Cai, Y., Ling, Z., Heimberg, H., Hue, L., Pipeleers, D. and Van de Casteele, M. (2003) AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J. Mol. Endocrinol. 30, 151-161
189. Kefas, B. A., Heimberg, H., Vaulont, S., Meisse, D., Hue, L., Pipeleers, D. and Van de Casteele, M. (2003) AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia 46, 250-254
190. Culmsee, C., Monnig, J., Kemp, B. E. and Mattson, M. P. (2001) AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J. Mol. Neurosci. 17, 45-58
191. Blazquez, C., Geelen, M. J., Velasco, G. and Guzman, M. (2001) The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett. 489, 149-153
192. Kato, K., Ogura, T., Kishimoto, A., Minegishi, Y., Nakajima, N., Miyazaki, M. and Esumi, H. (2002) Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 21, 6082-6090
193. Hue, L., Beauloye, C., Bertrand, L., Horman, S., Krause, U., Marsin, A. S., Meisse, D., Vertommen, D. and Rider, M. H. (2003) New targets of AMP-activated protein kinase. Biochem. Soc. Trans. 31, 213-215
194. Iglesias, M. A., Ye, J. M., Frangioudakis, G., Saha, A. K., Tomas, E., Ruderman, N. B., Cooney, G. J. and Kraegen, E. W. (2002) AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51, 2886-2894
195. Wu, M. S., Johnston, P., Sheu, W. H., Hollenbeck, C. B., Jeng, C. Y., Goldfine, I. D., Chen, Y. D. and Reaven, G. M. (1990) Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13, 1-8
196. Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G. and Gerich, J. E. (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333, 550-554
197. Kulkarni, R. N., Wang, Z. L., Wang, R. M., Hurley, J. D., Smith, D. M., Ghatei, M. A., Withers, D. J., Gardiner, J. V., Bailey, C. J. and Bloom, S. R. (1997) Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J. Clin. Invest. 100, 2729-2736
198. Kieffer, T. J., Keller, R. S., Leech, C. A., Holz, G. G. and Habener, J. F. (1997) Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes 46, 1087-1093
199. Seufert, J., Kieffer, T. J. and Habener, J. F. (1999) Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc. Natl. Acad. Sci. U.S.A. 96, 674-679
200. Harvey, J., McKay, N. G., Walker, K. S., Van der Kaay, J., Downes, C. P. and Ashford, M. L. (2000) Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line. J. Biol. Chem. 275, 4660-4669
201. Gregorio, F., Filipponi, P., Ambrosi, F., Cristallini, S., Marchetti, P., Calafiore, R., Navalesi, R. and Brunetti, P. (1989) Metformin potentiates B-cell response to high glucose: an in vitro study on isolated perfused pancreas from normal rats. Diabete Metab. 15, 111-117
202. Lupi, R., Marchetti, P., Giannarelli, R., Coppelli, A., Tellini, C., Del Guerra, S., Lorenzetti, M., Carmellini, M., Mosca, F. and Navalesi, R. (1997) Effects of glibenclamide and metformin (alone or in combination) on insulin release from isolated human pancreatic islets. Acta Diabetol. 34, 46-48
203. Giannaccini, G., Lupi, R., Trincavelli, M. L., Navalesi, R., Betti, L., Marchetti, P., Lucacchini, A., DelGuerra, S. and Martini, C. (1998) Characterization of sulfonylurea receptors in isoiated human pancreatic islets. J. Cell. Biochem. 71, 182-188
204. Levy, J. C., Matthews, D. R. and Hermans, M. P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191-2192
205. Unger, R. H. and Zhou, Y. T. (2001) Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50 (Suppl. 1), S118-S121
206. McGarry, J. D. and Dobbins, R. L. (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42, 128-138
207. Prentki, M. and Corkey, B. E. (1996) Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45, 273-283
208. Andreolas, C., da Silva Xavier, G., Diraison, F., Zhao, C., Varadi, A., Lopez-Casillas, F., Ferre, P., Foufelle, F. and Rutter, G. A. (2002) Stimulation of acetyl-CoA carboxylase gene expression by glucose requires insulin release and sterol regulatory element binding protein 1c in MIN6 β cells. Diabetes 51, 2536-2545
209. Wang, H., Maechler, P., Antinozzi, P. A., Herrero, L., Hagenfeldt-Johansson, K. A., Bjorklund, A. and Wollheim, C. B. (2003) The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction. J. Biol. Chem. 278, 16622-16629
210. Yang, X. J., Kow, L. M., Runabashi, T. and Mobbs, C. V. (1999) Hypothalamic glucose sensor - Similarities to and differences from pancreatic beta-cell mechanisms. Diabetes 48, 1763-1772
211. Levin, B. E., Dunn-Meynell, A. A. and Routh, V. H. (1999) Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am. J. Physiol. 276, R1223-R1231
212. Levin, B. E. (2002) Metabolic sensors: viewing glucosensing neurons from a broader perspective. Physiol. Behav. 76, 397-401
213. Jetton, T. L., Liang, Y., Pettepher, C. C., Zimmerman, E. C., Cox, F. G., Horvath, K., Matschinsky, F. M. and Magnuson, M. A. (1994) Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269, 3641-3654
214. Navarro, M., Rodriquez de Fonseca, F., Alvarez, E., Chowen, J. A., Zueco, J. A., Gomez, R., Eng, J. and Blazquez, E. (1996) Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J. Neurochem. 67, 1982-1991
215. Dunn-Meynell, A. A., Routh, V. H., Kang, L., Gaspers, L. and Levin, B. E. (2002) Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 51, 2056-2065
216. Miki, T., Liss, B., Minami, K., Shiuchi, T., Saraya, A., Kashima, Y., Horiuchi, M., Ashcroft, F., Minokoshi, Y., Roeper, J. and Seino, S. (2001) ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat. Neurosci. 4, 507-512
217. Schuit, F. C., Huypens, P., Heimberg, H. and Pipeleers, D. G. (2001) Glucose sensing in pancreatic beta-cells - A model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 50, 1-11
218. Ainscow, E. K., Mirshamsi, S., Tang, T., Ashford, M. J. and Rutter, G. A. (2002) Dynamic imaging of free cytosolic ATP concentration during fuel sensing by hypothalamic neurones: evidence for ATP-independent control of ATP-sensitive K+ channels. J. Physiol. (Cambridge, U.K.) 544, 429-445
219. Burdakov, D. and Ashcroft, F. M. (2002) Shedding new light on brain metabolism and glial function. J. Physiol. (Cambridge, U.K.) 544, 334
220. Aguirre, V., Uchida, T., Yenush, L., Davis, R. and White, M. F. (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275, 9047-9054
221. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., Karin, M. and Hotamisligil, G. S. (2002) A central role for JNK in obesity and insulin resistance. Nature (London) 420, 333-336
222. De Fea, K. and Roth, R. A. (1997) Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J. Biol. Chem 272, 31400-31406
223. da Silva Xavier, G., Varadi, A., Ainscow, E. and Butter, G. A. (2000) Regulation of gene expression by glucose in pancreatic β-cells (MIN6) via insulin secretion and activation of priosphatidyl inositol 3′ kinase. J. Biol. Chem. 275, 36269-36277
224. Leibiger, I. B., Leibiger, B., Moede, T. and Berggren, P. O. (1998) Exocytosis of insulin promotes insulin gene transcription via the insulin receptor PI-3 kinase p70 s6 kinase and CaM kinase pathways. Mol. Cell 1, 933-938
225. Jakobsen, S. N., Hardie, D. G., Morrice, N. and Tornqvist, H. E. (2001) 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276, 46912-46916
226. Vanhaesebroeck, B. and Alessi, D. R. (2000) The P13K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561-576
227. Dennis, P. B., Pullen, N., Kozma, S. C. and Thomas, G. (1996) The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell. Biol. 16, 6242-6251
228. Scherer, P. E., Bickel, P. E., Kotler, M. and Lodish, H. F. (1998) Cloning of cell-specific secreted and surface proteins by subtractive antibody screening. Nat. Biotechnol. 16, 581-586
229. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K. et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83
230. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295
231. Tomas, E., Tsao, T. S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F. and Ruderman, N. B. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 99, 16309-16313
232. Buhl, E. S., Jessen, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S. B., Pedersen, O., Schmitz, O. and Lund, S. (2002) Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51, 2199-2206
233. Turner, R. C., Cull, C. A., Frighi, V. and Holman, R. R. (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA, J. Am. Med. Assoc. 281, 2005-2012